Injected or Intravenously Administered Cancer Treatment Medication

On March 21, 2017, Gov. Hutchinson signed HB 1592 into law, creating Act 543. This legislation prohibits plans that provide coverage for injected or intravenously administered cancer treatment medications from providing less favorable coverage for prescribed, orally administered cancer treatment medications. Further, plans may not reclassify cancer treatment medications or increase copayments, deductibles or coinsurance for the medications that are injected or intravenously administered unless the increase is applied to all other medical and pharmaceutical benefits or the increase is consistent with the carrier’s annual increases in the cost of health care. Any reclassification must also be consistent with this legislation. This act is effective on Jan. 1, 2018.

Act 543 »